HomeAQST • NASDAQ
add
Aquestive Therapeutics Inc
Previous close
$2.47
Day range
$2.39 - $2.58
Year range
$2.20 - $5.80
Market cap
249.16M USD
Avg Volume
1.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 11.87M | -10.14% |
Operating expense | 20.93M | 68.24% |
Net income | -17.06M | -110.27% |
Net profit margin | -143.72 | -134.00% |
Earnings per share | -0.16 | -75.25% |
EBITDA | -13.41M | -292.42% |
Effective tax rate | 0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.55M | 199.71% |
Total assets | 101.42M | 76.64% |
Total liabilities | 161.58M | -1.42% |
Total equity | -60.16M | — |
Shares outstanding | 98.87M | — |
Price to book | -3.74 | — |
Return on assets | -32.12% | — |
Return on capital | 221.13% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -17.06M | -110.27% |
Cash from operations | -6.49M | -31.30% |
Cash from investing | -15.00K | 6.25% |
Cash from financing | 157.00K | -95.99% |
Net change in cash | -6.35M | -507.37% |
Free cash flow | -182.88K | 90.90% |
About
Founded
2004
Headquarters
Website
Employees
142
